Rs. 475 Dividend: Blue Chip Pharma Stock To Reward Shareholders In August, Record Date In July Last Week; Buy?

In India, Abbott India Limited is a division of Abbott's worldwide pharmaceutical business. Abbott India provides a wide range of products and services, such as medications, medical equipment, diagnostics, and nutritional supplements. Abbott India Limited, a publicly traded corporation with its headquarters located in Mumbai and a subsidiary of Abbott Laboratories, prides itself on providing high-quality, reliable medications in a variety of therapeutic areas, including primary care, metabolic disorders, cardiology, gastroenterology, and women's health. Abbott India will soon give shareholders the highest dividend distribution in history, totalling Rs. 475. The company is in the headlines since the record date falls in July.

Abbott India Dividend

"We are pleased to inform you that the Board of Directors at its Meeting held on May 15, 2025, recommended a final dividend of Rs. 475/- per equity share of Rs 10/- each for the financial year ended March 31, 2025 ("Dividend"), subject to approval of the Members at the ensuing Annual General Meeting to be held on August 13, 2025. The Dividend, if approved by the Members, will be paid on or after August 18, 2025, to the Members whose names appear on the Register of Members and to the Beneficial Owners of the Shares as on July 25, 2025 ("Record date"), as per the details furnished by the Depositories for this purpose," said Abbott India in a stock exchange filing.

Closure of Trading Window of Abbott India Ahead of Q1 Results

"This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Shares of the Company by the Designated Persons and their immediate relatives shall be closed from Tuesday, July 1, 2025 and the same shall reopen after 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ending on June 30, 2025," Abbott India confirmed in a regulatory filing.

Abbott India Share Price Target

"ABBOTINDIA is currently trading near ₹35,300 and has recently witnessed a strong breakout from a prolonged consolidation zone. Post-breakout, the stock rallied over 15% with robust volume, signaling strong bullish sentiment. The price action is also forming a classic higher high, higher low structure, which indicates a continued uptrend. A decisive close above the resistance level of ₹35,560 may pave the way for further upward momentum," commented Mandar Bhojane - Senior Equity Research Analyst at Choice Broking.

"From a technical standpoint, the RSI is hovering around 79 and trending upwards, suggesting strong price strength and buying momentum. Additionally, the Stochastic RSI has given a positive crossover, reinforcing the bullish setup. Immediate support is placed around ₹34,500 and ₹34,000 zones, and any dip near these levels can be seen as a 'buy on dips' opportunity. On the upside, potential targets are placed at ₹37,500 and ₹38,000 in the short to medium term," the analyst further added.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.